Robert L. Myers - 23 Sep 2021 Form 4 Insider Report for Predictive Oncology Inc. (POAI)

Role: Chief Financial Officer
Signature: /s/ Bob Myers
Issuer symbol: POAI
Transactions as of: 23 Sep 2021
Net transactions value: +$26,141
Form type: 4
Filing time: 24 Sep 2021, 16:07:47 UTC
Next filing: 20 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	POAI	Common Stock, $.01 par value	Options Exercise	$37,667	+33,334	+43291%	$1.13	33,411	23 Sep 2021	Direct	F1, F2
transaction	POAI	Common Stock, $.01 par value	Disposed to Issuer	$11,526	-10,200	-31%	$1.13	23,211	23 Sep 2021	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	POAI	Restricted Stock Units	Options Exercise	$0	-33,334	-33%	$0.000000	66,666	23 Sep 2021	Common Stock	33,334		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
F2	On September 23, 2020, the reporting person was granted 100,000 restricted stock units, vesting in three annual installments beginning on the first anniversary of the grant date. The first of these installments vests on September 23, 2021. The remainder vests on each of 9/23/2022 and 9/23/2023.
F3	10,200 shares of common stock forfeited to Company on September 23, 2021 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.